Prenatal Screening - PrePare II

Prenatal Screening - PrePare II Overview

PrePare II second trimester screening is performed between the 15th and 20th gestational week. However, if an expectant mom misses the first-trimester screening, then PrePare II is strongly recommended for screening chromosomal abnormalities.

What does this test screen for?

Quadruple Marker Screening: It is a blood test that typically screens for markers of certain abnormalities (Edward’s Syndrome, Down’s Syndrome) and birth defects (Open Neural Tube Defects).

Prenatal Screening - PrePare II helps prospective mothers in more ways than one

Help prospective parents prepare and assess options for future pregnancy.

Help doctors to closely examine the fetus for any other signs of underlying complications.

Reduces the need for mother’s to go through high-risk invasive testing

Ensures results in just 48-72 hours

Provides Free Genetic Counselling after the test to understand your results better.

How Does Prenatal Screening - PrePare II Work?

Booking The Test

Doctor places an order for the test.

Collection

The sample is collected and shipped to the lab.

Laboratory Analysis

Testing and analysis of the sample is conducted in the lab.

Reports

The results are shared within 48 - 72 hours.

Counselling

Post-result free genetic counselling is offered to parents to understand the test results better.

Begin your healthy pregnancy journey with

Prenatal Screening - PrePare II

KNOW MORE

Please note that Prenatal Screening - PrePare II can only be ordered by a physician. They would also be the only person to receive your results and will pass them along to you. If you are unable to find a physician, contact us on 1800-266-5533 & we will organise one for you at no additional cost.

Frequently Asked Questions

Yes. Ideally, second-trimester screening should be carried out regardless of having performed first-trimester screening. It is especially recommended if the pregnant woman were to miss the First-trimester testing.

The quadruple marker screening tests for an additional marker, Inhibin A and provides a higher detection rate that the triple marker test (70-75% Vs. 65-70%).